SCD2 Alleviates Diabetes‐Associated Cognitive Dysfunction by Improving Microglial Lipid Metabolism
Cell Proliferation · 2026
DOI: 10.1111/cpr.70221 ↗At a glance
Journal article in Cell Proliferation, 2026. Written by Yang Yang and 5 co-authors. Institution: Department of Endocrinology and Metabolism, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Major MEDLINE topics: Microglia, Stearoyl-CoA Desaturase, Lipid Metabolism, Cognitive Dysfunction. 39 references. The full text is freely available (open access, CC BY 4.0). Funded by: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Key Advantageous Discipline Construction Project of Guizhou Provincial Health Commission in 2024, Guizhou Province Science and Technology Project for qian ke he zhongda [2025] 008.
Topics: Diabetes mellitus
Abstract (original language)
The mechanisms underlying diabetes‐associated cognitive dysfunction (DACD) are not fully understood, and microglial metabolic dysfunction is emerging as a key contributor. This study investigates whether stearoyl‐CoA desaturase 2 (SCD2) alleviates cognitive impairment by modulating microglial lipid metabolism and function. Bioinformatics analysis of a single‐cell RNA‐seq dataset (GSE201644) identified SCD2 downregulation in diabetic (db/db) microglia. A T2D mouse model underwent hippocampal overexpression of SCD2 via AAV injection. In vitro, high glucose (HG)‐treated BV2 microglia‐like cells were subjected to SCD2 overexpression or oleic acid (OA) supplementation. Mitochondrial function (OCR, ATP, ETC complexes), lipid droplet accumulation (BODIPY, PLIN2), and inflammation (TNF‐α, IL‐6) were assessed. Cognitive behaviour (MWM, NOR) and neurophysiology (synaptic markers, neuronal survival) were evaluated. Diabetic microglia exhibited reduced SCD2 expression, impaired oxidative phosphorylation and lipid droplet accumulation (LDAM). SCD2 overexpression or OA rescued mitochondrial function, mitigated lipid droplet accumulation and attenuated inflammation. In vivo, hippocampal SCD2 overexpression attenuated neuroinflammation, preserved synaptic integrity and improved cognition in diabetic mice. SCD2 is essential for maintaining microglial lipid and mitochondrial homeostasis in diabetes. Restoring SCD2 function alleviates neuroinflammation and synaptic deficits, thereby rescuing cognitive impairment, highlighting its therapeutic potential for DACD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Endocrinology and Metabolism, GuiQian International General Hospital, Guiyang, Guizhou, China.
ORCID profiles: Miao Zhang
Funding
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Key Advantageous Discipline Construction Project of Guizhou Provincial Health Commission in 2024
- Guizhou Province Science and Technology Project for qian ke he zhongda [2025] 008
- Doctor Start-up Fund of Affiliated Hospital of Guizhou Medical University
- The Foundation Project for Science and Technology of Guizhou Provincial Health Commission in 2026
- The Project of Researching and Educating Students and Research Feedback on Teaching at the Affiliated Hospital of Guizhou Medical University in 2025
Cite
APA
Yang, Y., He, J., Zheng, J., Shao, B., Shi, L., & Zhang, M. (2026). SCD2 Alleviates Diabetes‐Associated Cognitive Dysfunction by Improving Microglial Lipid Metabolism. Cell Proliferation. https://doi.org/10.1111/cpr.70221
Vancouver
Yang Y, He J, Zheng J, Shao B, Shi L, Zhang M. SCD2 Alleviates Diabetes‐Associated Cognitive Dysfunction by Improving Microglial Lipid Metabolism. Cell Proliferation. 2026. doi:10.1111/cpr.70221
BibTeX
@article{Yang2026,
author = {Yang, Yang and He, Juan and Zheng, Jing and Shao, Bing and Shi, Lixin and Zhang, Miao},
title = {SCD2 Alleviates Diabetes‐Associated Cognitive Dysfunction by Improving Microglial Lipid Metabolism},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70221}
}
EUVIMED